Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fear | 62 | 2019 | 249 | 13.640 |
Why?
|
| Extinction, Psychological | 54 | 2019 | 90 | 12.190 |
Why?
|
| Prefrontal Cortex | 42 | 2022 | 137 | 10.140 |
Why?
|
| Amygdala | 31 | 2020 | 114 | 5.450 |
Why?
|
| Avoidance Learning | 13 | 2024 | 62 | 5.070 |
Why?
|
| Conditioning, Classical | 22 | 2016 | 61 | 4.080 |
Why?
|
| Memory | 19 | 2015 | 170 | 3.810 |
Why?
|
| Neurons | 27 | 2019 | 1175 | 2.870 |
Why?
|
| Rats | 57 | 2022 | 3483 | 2.810 |
Why?
|
| Obsessive-Compulsive Disorder | 7 | 2024 | 22 | 2.450 |
Why?
|
| Rats, Sprague-Dawley | 42 | 2020 | 1618 | 2.360 |
Why?
|
| Hippocampus | 11 | 2018 | 561 | 1.990 |
Why?
|
| Animals | 83 | 2022 | 15081 | 1.950 |
Why?
|
| Limbic System | 7 | 2018 | 25 | 1.790 |
Why?
|
| Neural Pathways | 17 | 2024 | 124 | 1.760 |
Why?
|
| Mental Recall | 10 | 2012 | 78 | 1.740 |
Why?
|
| Conditioning, Operant | 11 | 2016 | 73 | 1.700 |
Why?
|
| Cerebral Cortex | 8 | 2022 | 290 | 1.600 |
Why?
|
| Brain-Derived Neurotrophic Factor | 4 | 2018 | 61 | 1.550 |
Why?
|
| Anxiety Disorders | 7 | 2017 | 309 | 1.450 |
Why?
|
| Neurosciences | 6 | 2022 | 28 | 1.430 |
Why?
|
| Neuronal Plasticity | 9 | 2018 | 103 | 1.410 |
Why?
|
| Implosive Therapy | 3 | 2020 | 11 | 1.390 |
Why?
|
| Action Potentials | 17 | 2019 | 231 | 1.340 |
Why?
|
| Brain Mapping | 9 | 2016 | 112 | 1.280 |
Why?
|
| Nerve Net | 5 | 2020 | 76 | 1.190 |
Why?
|
| Rodentia | 3 | 2022 | 43 | 1.150 |
Why?
|
| Behavior, Animal | 16 | 2019 | 314 | 1.130 |
Why?
|
| Male | 59 | 2024 | 20025 | 1.130 |
Why?
|
| Brain | 9 | 2024 | 1346 | 1.060 |
Why?
|
| Neural Inhibition | 4 | 2018 | 48 | 1.020 |
Why?
|
| Association Learning | 7 | 2010 | 30 | 0.950 |
Why?
|
| Yohimbine | 3 | 2009 | 26 | 0.930 |
Why?
|
| Adrenergic alpha-Antagonists | 3 | 2009 | 31 | 0.930 |
Why?
|
| Proto-Oncogene Proteins c-fos | 5 | 2018 | 82 | 0.890 |
Why?
|
| Time Factors | 15 | 2015 | 1742 | 0.840 |
Why?
|
| Deep Brain Stimulation | 4 | 2016 | 9 | 0.820 |
Why?
|
| Signal Transduction | 4 | 2018 | 1908 | 0.820 |
Why?
|
| Corpus Striatum | 3 | 2020 | 104 | 0.810 |
Why?
|
| Thalamus | 4 | 2020 | 30 | 0.790 |
Why?
|
| Research | 4 | 2019 | 163 | 0.790 |
Why?
|
| Cues | 4 | 2017 | 55 | 0.710 |
Why?
|
| Reward | 3 | 2020 | 79 | 0.710 |
Why?
|
| Nucleus Accumbens | 2 | 2017 | 82 | 0.700 |
Why?
|
| Sucrose | 2 | 2017 | 26 | 0.700 |
Why?
|
| Analysis of Variance | 10 | 2015 | 550 | 0.690 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 1371 | 0.620 |
Why?
|
| Acoustic Stimulation | 12 | 2015 | 66 | 0.610 |
Why?
|
| Biomedical Research | 3 | 2021 | 400 | 0.610 |
Why?
|
| Learning | 4 | 2007 | 117 | 0.570 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2024 | 481 | 0.570 |
Why?
|
| Developing Countries | 4 | 1999 | 99 | 0.560 |
Why?
|
| Minority Groups | 2 | 2021 | 596 | 0.540 |
Why?
|
| Humans | 41 | 2024 | 37093 | 0.530 |
Why?
|
| Muscimol | 5 | 2016 | 15 | 0.500 |
Why?
|
| Gyrus Cinguli | 5 | 2022 | 25 | 0.490 |
Why?
|
| Stress Disorders, Post-Traumatic | 6 | 2019 | 389 | 0.470 |
Why?
|
| Amphetamine | 2 | 2014 | 16 | 0.460 |
Why?
|
| Ethanol | 1 | 2015 | 192 | 0.450 |
Why?
|
| Electroshock | 6 | 2012 | 17 | 0.450 |
Why?
|
| Appetitive Behavior | 1 | 2013 | 11 | 0.450 |
Why?
|
| Sensory Gating | 1 | 2012 | 6 | 0.440 |
Why?
|
| Basal Ganglia | 1 | 2012 | 17 | 0.420 |
Why?
|
| Propranolol | 2 | 2009 | 18 | 0.420 |
Why?
|
| Midline Thalamic Nuclei | 1 | 2011 | 1 | 0.410 |
Why?
|
| Emotions | 3 | 2006 | 220 | 0.410 |
Why?
|
| Central Nervous System Stimulants | 2 | 2014 | 174 | 0.390 |
Why?
|
| Cognition | 4 | 2020 | 398 | 0.370 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2010 | 34 | 0.370 |
Why?
|
| Puerto Rico | 4 | 2019 | 1378 | 0.370 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2010 | 73 | 0.360 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2010 | 137 | 0.360 |
Why?
|
| Freezing Reaction, Cataleptic | 4 | 2019 | 15 | 0.340 |
Why?
|
| Mesencephalon | 1 | 2009 | 41 | 0.330 |
Why?
|
| Anxiety | 5 | 2020 | 754 | 0.330 |
Why?
|
| Substance-Related Disorders | 2 | 2009 | 730 | 0.330 |
Why?
|
| Schizophrenia | 1 | 2009 | 76 | 0.320 |
Why?
|
| Norepinephrine | 1 | 2008 | 110 | 0.300 |
Why?
|
| Electric Stimulation | 9 | 2016 | 184 | 0.280 |
Why?
|
| Safety | 1 | 2007 | 48 | 0.280 |
Why?
|
| Entorhinal Cortex | 1 | 2006 | 13 | 0.280 |
Why?
|
| Nutrition Disorders | 2 | 1998 | 12 | 0.280 |
Why?
|
| Models, Neurological | 3 | 2013 | 128 | 0.260 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 53 | 0.260 |
Why?
|
| Motor Activity | 4 | 2014 | 418 | 0.250 |
Why?
|
| Honduras | 4 | 2017 | 7 | 0.250 |
Why?
|
| Memory Disorders | 1 | 2005 | 73 | 0.250 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 2 | 2017 | 25 | 0.250 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2004 | 21 | 0.250 |
Why?
|
| Locomotion | 2 | 2018 | 97 | 0.240 |
Why?
|
| Auditory Cortex | 3 | 1998 | 11 | 0.230 |
Why?
|
| Cell Nucleus | 1 | 2005 | 366 | 0.230 |
Why?
|
| Excitatory Amino Acid Antagonists | 3 | 2010 | 99 | 0.210 |
Why?
|
| Affect | 2 | 2016 | 152 | 0.210 |
Why?
|
| Piperazines | 3 | 2010 | 111 | 0.200 |
Why?
|
| Cats | 3 | 2007 | 69 | 0.200 |
Why?
|
| Compulsive Behavior | 1 | 2022 | 30 | 0.200 |
Why?
|
| N-Methylaspartate | 1 | 2001 | 57 | 0.200 |
Why?
|
| Motor Cortex | 4 | 1995 | 22 | 0.190 |
Why?
|
| Galvanic Skin Response | 4 | 2014 | 14 | 0.190 |
Why?
|
| Recombinant Proteins | 2 | 2014 | 515 | 0.190 |
Why?
|
| Neurophysiology | 2 | 1997 | 9 | 0.180 |
Why?
|
| Journalism, Medical | 1 | 2019 | 5 | 0.180 |
Why?
|
| Information Dissemination | 1 | 2019 | 59 | 0.170 |
Why?
|
| Pyramidal Tracts | 3 | 1995 | 13 | 0.170 |
Why?
|
| Corticosterone | 1 | 2019 | 77 | 0.170 |
Why?
|
| Injections, Intraperitoneal | 2 | 2009 | 60 | 0.170 |
Why?
|
| Reaction Time | 6 | 2013 | 143 | 0.170 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 80 | 0.170 |
Why?
|
| Behavior Therapy | 2 | 2010 | 167 | 0.160 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 1998 | 9 | 0.160 |
Why?
|
| Communication | 1 | 2019 | 180 | 0.150 |
Why?
|
| Growth Disorders | 1 | 1998 | 22 | 0.150 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 610 | 0.150 |
Why?
|
| Brain Ischemia | 1 | 2019 | 184 | 0.150 |
Why?
|
| Macaca | 2 | 2016 | 38 | 0.150 |
Why?
|
| Astrocytes | 1 | 2019 | 255 | 0.140 |
Why?
|
| Central Nervous System | 1 | 1998 | 135 | 0.140 |
Why?
|
| Evoked Potentials | 4 | 2006 | 87 | 0.140 |
Why?
|
| Internal Capsule | 1 | 2016 | 2 | 0.140 |
Why?
|
| Microinjections | 1 | 2016 | 57 | 0.140 |
Why?
|
| Laboratories | 1 | 1995 | 35 | 0.130 |
Why?
|
| Morphine | 1 | 2016 | 85 | 0.130 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2015 | 93 | 0.130 |
Why?
|
| Social Behavior | 1 | 2016 | 131 | 0.130 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 143 | 0.130 |
Why?
|
| Torture | 1 | 1994 | 1 | 0.130 |
Why?
|
| Massachusetts | 1 | 2014 | 31 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 1039 | 0.130 |
Why?
|
| Electrodes, Implanted | 3 | 2004 | 16 | 0.130 |
Why?
|
| Reinforcement Schedule | 2 | 2004 | 14 | 0.120 |
Why?
|
| Politics | 1 | 1994 | 40 | 0.120 |
Why?
|
| Synaptic Transmission | 1 | 1995 | 146 | 0.120 |
Why?
|
| Glutamic Acid | 1 | 2015 | 128 | 0.120 |
Why?
|
| Mental Disorders | 2 | 2009 | 309 | 0.120 |
Why?
|
| Antibodies | 1 | 2014 | 141 | 0.110 |
Why?
|
| Long-Term Potentiation | 2 | 2006 | 102 | 0.110 |
Why?
|
| Violence | 1 | 1994 | 134 | 0.110 |
Why?
|
| Auditory Perception | 1 | 2014 | 48 | 0.110 |
Why?
|
| Family | 1 | 1994 | 173 | 0.110 |
Why?
|
| Educational Status | 1 | 2014 | 313 | 0.110 |
Why?
|
| Electrophysiology | 5 | 2008 | 136 | 0.110 |
Why?
|
| Female | 11 | 2024 | 20969 | 0.110 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 108 | 0.110 |
Why?
|
| Oncogene Proteins v-fos | 1 | 2011 | 4 | 0.100 |
Why?
|
| Polymorphism, Genetic | 1 | 2013 | 191 | 0.100 |
Why?
|
| GABA Agonists | 1 | 2011 | 21 | 0.100 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 2231 | 0.100 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 80 | 0.100 |
Why?
|
| Age Factors | 1 | 2014 | 1033 | 0.100 |
Why?
|
| Species Specificity | 2 | 2016 | 245 | 0.100 |
Why?
|
| Sex Factors | 1 | 2014 | 898 | 0.100 |
Why?
|
| Raclopride | 1 | 2010 | 8 | 0.100 |
Why?
|
| Dopamine Antagonists | 1 | 2010 | 44 | 0.090 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2010 | 28 | 0.090 |
Why?
|
| Darkness | 1 | 1990 | 27 | 0.090 |
Why?
|
| Behavior | 1 | 2010 | 32 | 0.090 |
Why?
|
| Adult | 8 | 2024 | 11712 | 0.090 |
Why?
|
| Mice | 3 | 2019 | 5913 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 893 | 0.090 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2009 | 39 | 0.090 |
Why?
|
| Photic Stimulation | 1 | 2010 | 115 | 0.090 |
Why?
|
| Models, Psychological | 1 | 2010 | 131 | 0.090 |
Why?
|
| Sotalol | 1 | 2009 | 1 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2009 | 117 | 0.080 |
Why?
|
| Thionucleotides | 1 | 2008 | 9 | 0.080 |
Why?
|
| Pyramidal Cells | 1 | 2008 | 63 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2008 | 52 | 0.080 |
Why?
|
| Expressed Emotion | 1 | 2007 | 6 | 0.080 |
Why?
|
| Psychiatry | 1 | 2007 | 27 | 0.080 |
Why?
|
| Heart Rate | 1 | 2009 | 253 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2008 | 141 | 0.070 |
Why?
|
| Synapses | 1 | 2008 | 180 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 122 | 0.070 |
Why?
|
| Cyclic AMP | 1 | 2008 | 131 | 0.070 |
Why?
|
| United States | 1 | 2017 | 4223 | 0.070 |
Why?
|
| Tetrodotoxin | 1 | 2006 | 22 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2008 | 343 | 0.070 |
Why?
|
| Anesthetics, Local | 1 | 2006 | 22 | 0.070 |
Why?
|
| Radionuclide Imaging | 1 | 2006 | 28 | 0.070 |
Why?
|
| Models, Animal | 1 | 2006 | 134 | 0.070 |
Why?
|
| Snails | 1 | 2005 | 29 | 0.060 |
Why?
|
| Anisomycin | 1 | 2004 | 8 | 0.060 |
Why?
|
| Injections, Intraventricular | 1 | 2004 | 64 | 0.060 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2004 | 48 | 0.060 |
Why?
|
| Harm Reduction | 1 | 2024 | 21 | 0.060 |
Why?
|
| Microelectrodes | 1 | 2003 | 23 | 0.060 |
Why?
|
| Brain Stem | 1 | 2003 | 50 | 0.060 |
Why?
|
| Sound | 1 | 2002 | 7 | 0.050 |
Why?
|
| Latin America | 1 | 2022 | 45 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2019 | 1369 | 0.050 |
Why?
|
| Panic Disorder | 1 | 2003 | 100 | 0.050 |
Why?
|
| Young Adult | 2 | 2024 | 4268 | 0.050 |
Why?
|
| Maryland | 1 | 2021 | 53 | 0.050 |
Why?
|
| Habits | 1 | 2020 | 7 | 0.050 |
Why?
|
| Denervation | 1 | 2000 | 27 | 0.050 |
Why?
|
| Neural Conduction | 2 | 1998 | 17 | 0.040 |
Why?
|
| Dependovirus | 1 | 2019 | 12 | 0.040 |
Why?
|
| Public Opinion | 1 | 1999 | 17 | 0.040 |
Why?
|
| Research Personnel | 1 | 2021 | 155 | 0.040 |
Why?
|
| Cerebellum | 1 | 2019 | 73 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2000 | 136 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2000 | 259 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2013 | 455 | 0.040 |
Why?
|
| Nerve Degeneration | 1 | 2019 | 107 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 2 | 2010 | 223 | 0.040 |
Why?
|
| Neuroglia | 1 | 2019 | 124 | 0.040 |
Why?
|
| Child | 2 | 1998 | 3131 | 0.040 |
Why?
|
| Spinal Cord | 2 | 1990 | 94 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 617 | 0.040 |
Why?
|
| Forecasting | 1 | 1998 | 128 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1130 | 0.040 |
Why?
|
| Neuroanatomical Tract-Tracing Techniques | 1 | 2016 | 1 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 885 | 0.030 |
Why?
|
| Budgets | 1 | 1995 | 9 | 0.030 |
Why?
|
| Equipment and Supplies | 1 | 1995 | 10 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2007 | 173 | 0.030 |
Why?
|
| Oxygen | 2 | 2007 | 207 | 0.030 |
Why?
|
| Social Problems | 1 | 1995 | 14 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 1995 | 29 | 0.030 |
Why?
|
| Computers | 1 | 1995 | 35 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 1995 | 55 | 0.030 |
Why?
|
| Teaching | 1 | 1995 | 55 | 0.030 |
Why?
|
| Wheat Germ Agglutinins | 1 | 2015 | 7 | 0.030 |
Why?
|
| Bereavement | 1 | 1994 | 8 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 1995 | 51 | 0.030 |
Why?
|
| Grief | 1 | 1994 | 6 | 0.030 |
Why?
|
| Personality Assessment | 1 | 1994 | 42 | 0.030 |
Why?
|
| Program Development | 1 | 1995 | 233 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 1995 | 233 | 0.030 |
Why?
|
| Students, Medical | 1 | 1995 | 130 | 0.030 |
Why?
|
| Schools, Medical | 1 | 1995 | 198 | 0.030 |
Why?
|
| Cohort Studies | 1 | 1998 | 1492 | 0.030 |
Why?
|
| Curriculum | 1 | 1995 | 265 | 0.030 |
Why?
|
| Trauma Severity Indices | 1 | 2013 | 26 | 0.030 |
Why?
|
| Methionine | 1 | 2013 | 30 | 0.030 |
Why?
|
| Valine | 1 | 2013 | 31 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 13 | 0.030 |
Why?
|
| Rest | 1 | 2012 | 26 | 0.030 |
Why?
|
| Urethane | 1 | 1992 | 1 | 0.030 |
Why?
|
| Anesthesia | 1 | 1992 | 14 | 0.030 |
Why?
|
| Television | 1 | 1992 | 28 | 0.030 |
Why?
|
| Theta Rhythm | 1 | 1992 | 7 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 400 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 1994 | 385 | 0.020 |
Why?
|
| Magnetics | 1 | 1990 | 36 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2010 | 103 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 730 | 0.020 |
Why?
|
| Light | 1 | 1990 | 187 | 0.020 |
Why?
|
| Space Perception | 1 | 1987 | 33 | 0.020 |
Why?
|
| Psychophysics | 1 | 2007 | 12 | 0.020 |
Why?
|
| Rats, Inbred Strains | 3 | 1992 | 133 | 0.020 |
Why?
|
| Adolescent | 1 | 1994 | 5363 | 0.010 |
Why?
|
| Efferent Pathways | 2 | 1990 | 14 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 10129 | 0.010 |
Why?
|
| Walking | 1 | 1992 | 68 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1990 | 116 | 0.010 |
Why?
|
| Naloxone | 1 | 1987 | 52 | 0.000 |
Why?
|
| Scalp | 1 | 1987 | 12 | 0.000 |
Why?
|
| Muscles | 1 | 1987 | 82 | 0.000 |
Why?
|
| Interneurons | 1 | 1987 | 56 | 0.000 |
Why?
|
| Motor Neurons | 1 | 1987 | 83 | 0.000 |
Why?
|